New Product Planning

Overview

A global biopharmaceutical company on a mission to Solve On, Incyte follows science to find solutions for patients with unmet medical needs. Through the discovery, development, and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Hematology, Oncology and Inflammation and Autoimmunity

Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe, and Asia.

Sr. Director, New Product Planning (NPP) Lead serves as the strategic bridge between R&D, Global, and US Commercial, shaping oncology assets 2–5 years prior to launch. This role drives asset strategy, market development, and organizational readiness to maximize long-term value and ensure successful commercialization in new disease areas.

The position operates in a highly matrixed environment and plays a central role in portfolio decision-making, clinical development influence, and pre-launch strategy formation.

Core Responsibilities

• Product Planning: Co-develop Target Product Profiles (TPPs); provide US commercial input to trial design/evidence generation, regulatory/labeling strategy, and differentiation vs. standard of care; translate scientific and clinical data into commercial implications, risks, and opportunities; support assets from preclinical through Phase II/III decision points.
• Market Shaping: Build deep understanding of disease biology/paradigm, patient segmentation/unmet need, and competitive pipeline; lead market-shaping strategies (disease awareness, diagnostic pathway evolution, KOL engagement, scientific leadership positioning, early value proposition/positioning); generate insights through primary research, competitive intelligence, and analog analysis; anticipate future market dynamics and access environment (pricing, reimbursement, guidelines).
• Shape portfolio & investment decisions: Lead US commercial assessments (market sizing/epidemiology/patient flow, forecasting/valuation, scenario planning/risk); support governance forums (portfolio prioritization, stage-gate decisions, BD/licensing evaluations); recommend where to invest vs. deprioritize.
• Organizational Readiness: Drive cross-functional alignment (R&D, Medical, Market Access, Regulatory, Commercial); build early brand strategy and launch blueprint (positioning, value story, evidence plan, go-to-market hypotheses); define required future capabilities (field model, diagnostics, patient identification, payer engagement); establish a 2–5 year pre-launch roadmap and milestones.
• Cross-functional & external leadership: Serve as US commercial lead on global asset teams; influence senior stakeholders without direct authority; engage external stakeholders (KOLs, investigators, scientific societies); operate as a matrix leader across geographies and functions.
  
  

Qualifications

Education

• Bachelor’s degree required
• MBA or advanced degree preferred ( PharmD, MBA)
  
  

Experience

• 8–12 years in pharma/biotech
• Experience in one or more: New Product Planning; Clinical Development; Oncology Marketing/Market Access; Medical Affairs
  
  

Key Skills & Capabilities

• Strategic thinking: ability to connect science → market → value
• Oncology expertise: disease biology, clinical pathways, competitive landscape
• Immunology Experience
• Clinical-commercial integration: fluency in both domains
• Market shaping mindset (not just market entry)
• Advanced analytics: forecasting, valuation, scenario modeling
• Influence without authority in complex matrix organizations
• Strong communication: translating complex science into clear strategy